We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

79 hedge funds and large institutions have $111M invested in BioSpecifics Technologies Corp. in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 24

2% more capital invested

Capital invested by funds: $109M → $111M (+$1.78M)

7% less funds holding

Funds holding: 8579 (-6)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
2.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
33
Reduced
24
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DIA
51
Denver Investment Advisors
Colorado
$323K +$324K +8,259 New
Ameriprise
52
Ameriprise
Minnesota
$314K +$314K +8,019 New
Deutsche Bank
53
Deutsche Bank
Germany
$303K +$302K +7,709 +14,016%
California State Teachers Retirement System (CalSTRS)
54
California State Teachers Retirement System (CalSTRS)
California
$273K +$7.84K +200 +3%
CAM
55
ClariVest Asset Management
California
$242K
PP
56
PDT Partners
New York
$227K +$227K +5,800 New
TA
57
Teachers Advisors
New York
$198K
Asset Management One
58
Asset Management One
Japan
$151K
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$142K +$142K +3,633 New
First Manhattan
60
First Manhattan
New York
$112K
NFA
61
Nationwide Fund Advisors
Ohio
$105K -$1.76K -45 -2%
US Bancorp
62
US Bancorp
Minnesota
$99K
AIG
63
American International Group
New York
$93.6K
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$82K -$26.7K -681 -25%
BJ
65
BlackRock Japan
Japan
$46K -$4K -102 -8%
Barclays
66
Barclays
United Kingdom
$45K +$35.7K +911 +442%
MA
67
MUFG Americas
New York
$40K +$8.23K +210 +26%
AllianceBernstein
68
AllianceBernstein
Tennessee
$31K +$15.7K +400 +100%
TRCT
69
Tower Research Capital (TRC)
New York
$22K +$16K +407 +277%
SGAM
70
Smith Group Asset Management
Texas
$16K -$42.7K -1,090 -72%
FANJ
71
Financial Architects (New Jersey)
New Jersey
$13K
Citigroup
72
Citigroup
New York
$8K -$440K -11,217 -98%
UBS Group
73
UBS Group
Switzerland
$6K -$2.98K -76 -32%
MTIP
74
Magee Thomson Investment Partners
California
$5K +$627 +16 +13%
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$4K +$2.9K +74 +231%

BSTC Hedge Fund Activity: Q1 2015 in Review

79 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2015, worth a combined $111M — up 1.6% from $109M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of BSTC and 6 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 33 added.

The largest buyer was Rice Hall James & Associates, adding an estimated $1.53M. The largest seller was Armistice Capital, exiting entirely with an estimated $4.05M sold.

  • 79 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2015, down from 85 in Q4 2014.
  • Funds reported $111M of BioSpecifics Technologies Corp. stock for Q1 2015, up 1.6% quarter-over-quarter.
  • 6 funds opened new BioSpecifics Technologies Corp. positions in Q1 2015 and 12 closed out, a net change of -6 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q1 2015 was Rice Hall James & Associates, an estimated $1.53M added.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2015 was Armistice Capital, an estimated $4.05M sold.

Based on aggregated 13F filings for Q1 2015.